Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Date of authorisation: 23/04/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Status: Authorised

European Medicines Agency’s privacy statement for legal entity and bank account validation

Data protection and privacy at EMA

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 5, Status: Authorised

Champix

SME Regulation and reports